✦ LIBER ✦

Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women

✍ Scribed by Wen-Ling Lee; Hsiang-Tai Chao; Ming-Huei Cheng; Peng-Hui Wang

Book ID: 116731761
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 183 KB
Volume: 60
Category: Article
ISSN: 0378-5122
DOI: 10.1016/j.maturitas.2008.04.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The STAR results: choosing between ralox

The STAR results: choosing between raloxifene and tamoxifen for preventing invasive breast cancer in postmenopausal women

✍ Jame Abraham 📂 Article 📅 2006 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 85 KB

Role of raloxifene in breast cancer prev

Role of raloxifene in breast cancer prevention in postmenopausal women: Clinical evidence and potential mechanisms of action

✍ Michael B. Sporn; Sherie A. Dowsett; John Mershon; Henry U. Bryant 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 787 KB

Identifying cost-effective treatment wit

Identifying cost-effective treatment with raloxifene in postmenopausal women using risk algorithms for fractures and invasive breast cancer

✍ M. Ivergård; O. Ström; F. Borgström; R.T. Burge; A.N.A. Tosteson; J. Kanis 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 625 KB

Arzoxifene for prevention of fractures a

Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women

✍ Steven R Cummings; Michael McClung; Jean-Yves Reginster; David Cox; Bruce Mitlak 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 97 KB

## Abstract Arzoxifene is a selective estrogen receptor modulator (SERM) that has been shown to be more potent in preclinical testing than currently available agents. Its effects on clinical outcomes are not known. In a randomized, blinded trial, women aged 60 to 85 years with osteoporosis, defined

Prevention of Breast Cancer in Postmenop

Prevention of Breast Cancer in Postmenopausal Women: Approaches to Estimating and Reducing Risk

✍ Cook, E.D. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Prevention of osteoporosis as a conseque

Prevention of osteoporosis as a consequence of aromatase inhibitor therapy in postmenopausal women with early breast cancer: Rationale and design of a randomized controlled trial

✍ Sharon Kilbreath; Kathryn M. Refshauge; Jane Beith; Leigh Ward; Kate Sawkins; Ro 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 168 KB